Delivery Order SPE2DB20D2104-SPE2DB24FR48Z
Award Date 12/5/23
Potential Completion Date 12/6/23
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with ID SPE2DB22D1017|SPE2DB24FF1BT, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Glimepiride 4 mg tablets, a pharmaceutical product used to treat diabetes. The contract has a ceiling value of $5,031.97 and an ultimate completion date of January 11, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen Drug Corp, a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $7,913.49, is for the delivery of 4563017738 GLIMEPIRIDE 4 MG TABLET 100S. The contract type is a delivery order with a firm fixed price pricing structure, and the ultimate completion date is December 7, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $13,035.05 for the supply of 4 mg glimepiride tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of December 6, 2023 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Glimepiride 4 mg tablets, a diabetes medication, with a ceiling value of $1,711.76 and a completion date of June 18, 2025. This is a Firm Fixed Price Delivery Order contract, which is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,489.57 Firm Fixed Price delivery order is for the supply of GLIMEPIRIDE 1 MG TABLET 100S, a medication used in the treatment of diabetes. The contract has an ultimate completion date of February 15, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Glimepiride 4 mg tablets, a diabetes medication, with a ceiling value of $2,043.05 and a completion date of July 2, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a larger...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,330.04 firm fixed price delivery order is for the supply of 4 mg Glimepiride tablets, a medication used to treat diabetes. The contract has an ultimate completion date of October 28, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,516.60 for the supply of 4 mg glimepiride tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 29, 2023. The award is a firm fixed-price contract and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,204.75 delivery order contract is for the supply of the pharmaceutical drug Glimepiride 1 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of January 12, 2024. This award is not associated with a set-aside designation, indicating it was competed on an open market. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,629.34, is for the delivery of 4562955193 GLIMEPIRIDE 4 MG TABLET 100S. The contract is a Delivery Order with a Firm Fixed Price pricing type. The ultimate completion date for this award is December 1, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...